There is no cure for inherited color blindness. If you were born with color vision deficiency, no surgery, medication, or therapy can fully restore normal color vision today. That said, the landscape is shifting. Gene therapy has shown real results in early human trials, corrective glasses can change how colors appear in daily life, and some forms of color blindness caused by disease or medication are actually reversible. Here’s where things stand.
Why Inherited Color Blindness Can’t Be Fixed Yet
Color vision depends on three types of cone cells in your retina, each tuned to detect red, green, or blue light. In inherited color blindness, the genes responsible for building one or more of these cone types are either missing, duplicated incorrectly, or carry a mutation that makes the resulting protein nonfunctional. The most common form, red-green color blindness, traces back to genes on the X chromosome, which is why it affects roughly 1 in 12 men but only about 1 in 200 women.
In some cases, the cone cells themselves are physically present but contain the wrong light-sensing protein. In others, a single amino acid swap in the protein’s structure breaks a critical chemical bond, rendering the entire cone useless. Because these defects are baked into your DNA and present in every affected cell from birth, there’s no pill or procedure that can undo the problem after the retina has already developed around it.
Gene Therapy: The Closest Thing to a Cure
Gene therapy is the most promising path toward actually fixing color blindness at the cellular level. The idea is straightforward: deliver a working copy of the missing or broken gene directly into the cone cells of the retina using a harmless virus as a carrier. Researchers at the University of Washington successfully restored full color vision in squirrel monkeys that had been red-green color blind from birth, proving the concept works in primates.
Human trials are underway, though they’re focused first on achromatopsia, a rare and severe form of color blindness where none of the cone cells work properly. A phase 1/2 trial led by researchers at University College London and Moorfields Eye Hospital treated four children (ages 10 to 15) with gene therapy in one eye, leaving the other untreated for comparison. Before treatment, none of the children showed any measurable cone function. Six to 14 months later, two of the four showed clear evidence of cone-driven signals reaching the brain’s visual processing center from the treated eye. Their results on contrast tests closely resembled those of people with normal vision.
The other two children didn’t show detectable improvement on the tests used, though researchers note the effects could be delayed or simply not captured by current measurement tools. Overall trial results are still being compiled, and the therapy hasn’t been tested yet for the far more common red-green variety. The University of Washington team has been working with a biotech partner to develop a delivery method involving a single injection into the eye, but the jump from primate success to routine human treatment has taken longer than initially projected.
When Color Blindness Is Reversible
Not all color vision problems are genetic. Acquired color blindness can develop from a range of medical conditions, including diabetes, glaucoma, macular degeneration, multiple sclerosis, Parkinson’s disease, and chronic alcoholism. Certain medications, particularly hydroxychloroquine (used for rheumatoid arthritis), can also shift color perception. Eye trauma from injury, surgery, or radiation therapy is another cause.
The key difference is that acquired color blindness often improves or resolves entirely when the underlying condition is treated. If cataracts are yellowing your lens and washing out blues and purples, cataract surgery can restore color perception. If a medication is the culprit, switching to an alternative may bring your color vision back. Acquired cases also tend to affect one eye more than the other, which is a useful clue for distinguishing them from inherited deficiency.
What Color-Correcting Glasses Actually Do
EnChroma and similar brands sell glasses with specially engineered filters that selectively block narrow bands of light where red and green color signals overlap. The goal isn’t to fix your cones but to sharpen the difference between the signals your existing cones send to the brain.
A controlled study of 10 people with a common form of red-green deficiency (deuteranomaly) found that EnChroma filters did produce a measurable shift in color perception. Colors along the red-green axis appeared more distinct and vivid while wearing the glasses, and the enhancement matched what optical models predicted. However, the same study found minimal improvement in the ability to discriminate between colors at the threshold level, meaning fine distinctions that were invisible before stayed invisible. The glasses expand how colors look subjectively, but they don’t restore the missing information your cones can’t detect.
For many users, the experience is still meaningful. Seeing richer separation between reds and greens in a sunset or a garden can be genuinely striking, even if it doesn’t equal normal color vision. The glasses only work while you’re wearing them, they’re less effective indoors or in low light, and they do nothing for people who completely lack a cone type rather than having a weakened one.
Experimental Light Therapy
A newer and more surprising approach involves photobiomodulation, a therapy that uses specific wavelengths of light applied to the eye. A preliminary randomized trial published in Frontiers in Medicine tested this on people with congenital color vision deficiency and reported enough improvement to call the results “promising.” The mechanism isn’t fully understood, and the study was small, so this remains very early-stage. It’s worth watching but not something you can walk into a clinic and receive as a standard treatment.
Getting an Accurate Diagnosis
If you suspect you have a color vision deficiency but haven’t been formally tested, the type and severity of your condition matters for understanding which options might help you. The Ishihara plate test, the one with colored dots forming numbers, is the most common screening tool and catches red-green deficiency with about 83% sensitivity. It’s good for a quick yes-or-no answer but doesn’t measure severity well.
For a more detailed picture, the Farnsworth-Munsell 100 Hue Test asks you to arrange colored discs in order, revealing exactly where your color discrimination breaks down and how significantly. Digital versions of both tests exist, and some perform comparably to the physical versions, though accuracy varies by screen calibration. An eye care professional can determine whether your deficiency is inherited or acquired, which directly affects whether treatment could help.
Living With Color Blindness Now
While a true cure remains out of reach for inherited cases, practical tools have gotten better. Smartphone apps can identify colors in real time using your camera. Digital accessibility settings on phones and computers can shift color palettes to ones you can distinguish more easily. Color-coded systems at work or school can often be supplemented with labels, patterns, or symbols once you explain the need.
The gap between “no cure exists” and “nothing can be done” is wider than it used to be. Gene therapy may eventually close that gap entirely for at least some forms of color blindness, but for now, the realistic goal is better management and sharper tools rather than a fix.